THOMAS KIZY: Open Payments
NPI 1457637506 · ALGONAC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 44 payments from 15 companies in 2025. Trend: 2023 $798 · 2024 $611 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| Axsome Therapeutics, Inc. | 6 | $123 |
| ABBVIE INC. | 6 | $115 |
| Braeburn Inc. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $65 |
| Novo Nordisk Inc | 3 | $55 |
| Amgen Inc. | 3 | $50 |
| Indivior Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: BREZTRI, Auvelity, VRAYLAR, REXULTI, BRIXADI, AIRSUPRA, OTEZLA, Rybelsus.
Industry payments across MI — which companies pay providers there.
